Get the Stockscreener App
2.62
5.42%
-0.15
Collplant Biotechnologies Ltd stock is traded at $2.62, with a volume of 3,154.
It is down -5.42% in the last 24 hours and up +7.82% over the past month.
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
See More
Previous Close:
$2.77
Open:
$2.7
24h Volume:
3,154
Relative Volume:
0.03
Market Cap:
$33.32M
Revenue:
$2.47M
Net Income/Loss:
$-13.87M
P/E Ratio:
-2.1475
EPS:
-1.22
Net Cash Flow:
$-12.42M
1W Performance:
+3.97%
1M Performance:
+7.82%
6M Performance:
-25.14%
1Y Performance:
-51.93%
1-Day Range:
$2.60
$2.70
1-Week Range:
$2.39
$2.9699
52-Week Range:
$1.31
$5.45
Collplant Biotechnologies Ltd Stock (CLGN) Company Profile
Name
Collplant Biotechnologies Ltd
Sector
Industry
Phone
-
Address
-
Compare CLGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLGN
Collplant Biotechnologies Ltd
|
2.62 | 35.22M | 2.47M | -13.87M | -12.42M | -1.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Collplant Biotechnologies Ltd Stock (CLGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-17-23 | Initiated | Alliance Global Partners | Buy |
Collplant Biotechnologies Ltd Stock (CLGN) Latest News
Chart overlay techniques for tracking CollPlant Biotechnologies Ltd.July 2025 Highlights & Daily Stock Trend Watchlist - Newser
CollPlant Biotechnologies Ltd. stock chart pattern explainedIPO Watch & Risk Managed Investment Signals - Newser
Is it time to cut losses on CollPlant Biotechnologies Ltd.July 2025 Summary & Daily Stock Trend Reports - Newser
Key metrics from CollPlant Biotechnologies Ltd.’s quarterly dataTake Profit & Low Risk Entry Point Tips - Newser
Published on: 2025-08-31 13:24:15 - Newser
Sentiment analysis tools applied to CollPlant Biotechnologies Ltd.Weekly Gains Report & Verified Momentum Stock Alerts - Newser
Real time breakdown of CollPlant Biotechnologies Ltd. stock performance2025 Technical Patterns & Stepwise Entry/Exit Trade Alerts - Newser
Published on: 2025-08-31 00:57:30 - Newser
Building trade automation scripts for CollPlant Biotechnologies Ltd.Weekly Market Outlook & Free Real-Time Volume Trigger Notifications - Newser
What Fibonacci levels say about CollPlant Biotechnologies Ltd. reboundJuly 2025 Levels & Technical Entry and Exit Tips - Newser
What does recent volatility data suggest for CollPlant Biotechnologies Ltd.Trade Signal Summary & Growth Oriented Trading Recommendations - Newser
CollPlant Biotechnologies Ltd. stock volume spike explainedJuly 2025 Retail & Short-Term Trading Alerts - Newser
Candlestick signals on CollPlant Biotechnologies Ltd. stock todayMarket Risk Analysis & Low Volatility Stock Suggestions - Newser
Published on: 2025-08-30 20:42:48 - Newser
Will breakout in CollPlant Biotechnologies Ltd. lead to full recoveryMarket Trend Report & Growth Focused Entry Reports - Newser
Will a bounce in CollPlant Biotechnologies Ltd. offer an exitTrend Reversal & Expert Approved Momentum Ideas - Newser
Can CollPlant Biotechnologies Ltd. recover in the next quarter2025 Historical Comparison & Real-Time Stock Entry Alerts - Newser
Should you wait for a breakout in CollPlant Biotechnologies Ltd.July 2025 Fed Impact & Fast Gain Swing Trade Alerts - Newser
Is CollPlant Biotechnologies Ltd. still worth holding after the dipTreasury Yields & Fast Moving Stock Trade Plans - Newser
Will CollPlant Biotechnologies Ltd. bounce back from current supportTrade Analysis Summary & AI Optimized Trade Strategies - Newser
Is CollPlant Biotechnologies Ltd. trending in predictive chart modelsJuly 2025 Patterns & Free Community Consensus Stock Picks - Newser
Can trapped investors hope for a rebound in CollPlant Biotechnologies Ltd.2025 Technical Patterns & AI Driven Price Predictions - Newser
Guidance Update: What is CollPlant Biotechnologies Ltd.’s market positionTrade Risk Report & Short-Term High Return Strategies - sundaytimes.kr
Price momentum metrics for CollPlant Biotechnologies Ltd. explainedMarket Sentiment Review & Free High Return Stock Watch Alerts - Newser
Backtesting results for CollPlant Biotechnologies Ltd. trading strategies2025 Trading Recap & AI Forecast for Swing Trade Picks - Newser
Published on: 2025-08-28 23:36:00 - Newser
Collplant Biotechnologies Ltd Stock (CLGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.96%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):